More Articles

Generic or brand-name drugs for cardiovascular disease? Does the evidence match current opinion? Generics/Research | Posted 14/01/2011

Cardiovascular drugs constitute a large proportion of outpatient prescription drug spending.

The rise in power of generic drugs Generics/Research | Posted 14/01/2011

With shrinking pipelines, the impending expiration of many drug patents, and the global economic downturn experienced in the last two years causing prescription payers to face budget cuts, generic...

WHO prequalification programme for APIs Generics/News | Posted 14/01/2011

The WHO initiated on 21 October 2010 a pilot prequalification programme for selected active pharmaceutical ingredients (APIs) used in drugs for HIV and related diseases, antimalaria and anti-tuberc...

Safe supplies consortium hard at work Pharma News | Posted 14/01/2011

Perhaps frustrated at the length of time required for action on counterfeit drugs by the EMA or the FDA, and the limited powers of each of these bodies, a group of individuals got together last yea...

US drug shortages – frustration and safety concerns Reports | Posted 14/01/2011

According to a survey conducted by the non-profit ISMP, there is a high level of frustration and worries about safety, concerning recent drug shortages in the US.

China’s booming pharmaceutical market attracts R & D Pharma News | Posted 14/01/2011

China, which is approximately the size of the US, but with five times the population, has long been off-limits for global pharma due to its complex regulations, low healthcare expenditure and its s...

New medicines face big price cuts in Germany Policies & Legislation | Posted 14/01/2011

The pharmaceutical industry in Germany is facing price cuts expected to cost the industry more than Euros 2 billion per year, where parliament is set to approve the first price controls on newly ap...

FDA considering tighter controls on generics Generics/News | Posted 07/01/2011

The FDA may tighten standards for how closely generic drugs resemble brand-name equivalents. This comes as a result of complaints from both patients and employees of generic drugmakers that some of...